TIFFANY MINER: Open Payments
NPI 1710283783 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,212 in 140 payments from 18 companies in 2025. Trend: 2023 $3,244 · 2024 $4,392 · 2025 $6,212
Food & beverage: $4,667Consulting: $1,460Education: $85
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 13 | $1,022 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 14 | $968 |
| Botanix SB Inc | 18 | $891 |
| ABBVIE INC. | 12 | $560 |
| LEO Pharma Inc. | 8 | $445 |
| Galderma Laboratories, L.P. | 13 | $406 |
| Arcutis Biotherapeutics, Inc. | 7 | $311 |
| Regeneron Healthcare Solutions, Inc. | 5 | $250 |
| GENZYME CORPORATION | 12 | $239 |
| Incyte Corporation | 7 | $225 |
Products named: Bimzelx, SOFDRA, DUPIXENT, Winlevi, ILUMYA, SKYRIZI, Zoryve, ADBRY.
Industry payments across TX — which companies pay providers there.
